Munafa Stock Market Course + Intraday & FNO calls 
Allogene Therapeutics (ALLO) Technical (Analysis) Reports Allogene Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Allogene Therapeutics (ALLO)
Technical Analysis Report for NASDAQ stock ALLO Allogene Therapeutics. Dated: 16 Sep 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock ALLO Allogene Therapeutics then click here. or read Experts views on Allogene Therapeutics or Forecast & share price targets of Allogene Therapeutics
Allogene Therapeutics Opened at 1.74 and Closed at: 1.69, which is -1.78% of previous session's close. It moved within a range of 1.66 and 1.77
The session was a Bearish session with an average volume of 5610397, which is 44.06% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
A Dead cross was found 5 days back on mid term averages
A Dead cross was found 2 days back on long term averages
Support for tomorrow is 1.62 and resistance for tomorrow is 1.73
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 1.64, 1.6 resistance for tomorrow's hourly charts is 1.75, 1.82
10 Day SMA for Allogene Therapeutics (ALLO) is 1.83 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Allogene Therapeutics (ALLO) is 1.95 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Allogene Therapeutics (ALLO) is 1.93 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 2.01 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Allogene Therapeutics is 1.99 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Allogene Therapeutics is at 1.95 and 200 DMA is at 1.99, while 50 DMA and 100 DMA are at 1.93 and 2.01 respectively
Allogene Therapeutics (ALLO) moving average of 20 SMA is at 1.95 and 20 EMA is at 1.88
| Date | Closing Price | 20 SMA | 20 EMA |
| 16 Wed Sep | 1.69 | 1.95 | 1.88 |
| 15 Tue Sep | 1.72 | 1.97 | 1.9 |
| 14 Mon Sep | 1.79 | 1.99 | 1.92 |
| 11 Fri Sep | 1.78 | 2 | 1.93 |
| 10 Thu Sep | 1.76 | 2.01 | 1.95 |
| 09 Wed Sep | 1.73 | 2.02 | 1.97 |
Allogene Therapeutics (ALLO) moving average of 50 SMA is at 1.93 and 50 EMA is at 1.92
| Date | Closing Price | 50 SMA | 50 EMA |
| 16 Wed Sep | 1.69 | 1.93 | 1.92 |
| 15 Tue Sep | 1.72 | 1.94 | 1.93 |
| 14 Mon Sep | 1.79 | 1.94 | 1.94 |
| 11 Fri Sep | 1.78 | 1.95 | 1.95 |
| 10 Thu Sep | 1.76 | 1.96 | 1.96 |
| 09 Wed Sep | 1.73 | 1.96 | 1.97 |
Allogene Therapeutics (ALLO) moving average of 100 SMA is at 2.01 and 100 EMA is at 1.96
| Date | Closing Price | 100 SMA | 100 EMA |
| 16 Wed Sep | 1.69 | 2.01 | 1.96 |
| 15 Tue Sep | 1.72 | 2.01 | 1.97 |
| 14 Mon Sep | 1.79 | 2.02 | 1.98 |
| 11 Fri Sep | 1.78 | 2.02 | 1.98 |
| 10 Thu Sep | 1.76 | 2.03 | 1.98 |
| 09 Wed Sep | 1.73 | 2.03 | 1.98 |
Allogene Therapeutics (ALLO) moving average of 200 SMA is at 1.99 and 200 EMA is at 1.83
| Date | Closing Price | 200 SMA | 200 EMA |
| 16 Wed Sep | 1.69 | 1.99 | 1.83 |
| 15 Tue Sep | 1.72 | 1.99 | 1.83 |
| 14 Mon Sep | 1.79 | 1.98 | 1.83 |
| 11 Fri Sep | 1.78 | 1.98 | 1.83 |
| 10 Thu Sep | 1.76 | 1.98 | 1.83 |
| 09 Wed Sep | 1.73 | 1.98 | 1.83 |
Allogene Therapeutics has performed better than Synergetics Usa in short term. Holding Allogene Therapeutics could be a better choice for now!
Sonoma Pharmaceuticals has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Sonoma Pharmaceuticals, about 14% more returns!
Replimune Group has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Replimune Group, about 11.73% more returns!
Redhill Biopharma has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Redhill Biopharma, about 9.93% more returns!
Lakeland Industries has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Lakeland Industries, about 9.69% more returns!
Ironwood Pharmaceuticals has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Ironwood Pharmaceuticals, about 19.86% more returns!
Iovance Biotherapeutics has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Iovance Biotherapeutics, about 47.44% more returns!
Eyegate Pharmaceuticals has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Eyegate Pharmaceuticals, about 22.34% more returns!
Exelixis Inc has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Exelixis Inc, about 28.61% more returns!
Eton Pharmaceuticals has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Eton Pharmaceuticals, about 15.88% more returns!
Crispr Therapeutics has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Crispr Therapeutics, about 11.35% more returns!
Cocrystal Pharma has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Cocrystal Pharma, about 24.22% more returns!
Celcuity Inc has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Celcuity Inc, about 12.4% more returns!
Acadia Healthcare has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Acadia Healthcare, about 27.14% more returns!
Aurinia Pharmaceuticals has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Aurinia Pharmaceuticals, about 29.11% more returns!
Biomerica Inc has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Biomerica Inc, about 80.14% more returns!
Allogene Therapeutics Technical analysis of indicators
Price action analysis of Allogene Therapeutics (ALLO) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Allogene Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Allogene Therapeutics in short term and the sell signal is strong.
Allogene Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Allogene Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Allogene Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.82 and Allogene Therapeutics ALLO stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Allogene Therapeutics ALLO stock. Volume based technical analysis of Allogene Therapeutics ALLO stock is negative.
Allogene Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock ALLO Allogene Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And ALLO Experts View which covers a lot of information including buying and selling signals
ALLO future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Allogene Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Allogene Therapeutics (ALLO) Technical (Analysis) Reports Allogene Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
